Freestone Grove Partners LP

Position in MRK — Merck & Co., Inc.

CIK 2007591 San Francisco, CA

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,489,803

+$2,504,508 QoQ

Shares Held

27,158

+147.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,247

of 3,769 holders

Holding Since

Mar 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Freestone Grove Partners LP holds $182,044,995 across 6 Drug Manufacturers - General names. MRK ranks #6 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	517,230	$131,360,903
2	BIIB	Biogen Inc.	83,853	$18,117,279
3	LLY	ELI LILLY & Co	13,442	$16,122,739
4	PFE	Pfizer Inc	335,530	$8,079,562
5	BMY	Bristol Myers Squibb Co	84,601	$4,874,709
6	MRK	Merck & Co., Inc. This page	27,158	$3,489,803

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,489,803	27,158	+147.4%	Shares	Sole	2026-08-14
2025-03-31	$985,295	10,977	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.